Navigation Links
Consistent, Managed Treatment Works Best for Children With AD/HD
Date:11/16/2007

LANDOVER, Md., Nov. 16 /PRNewswire-USNewswire/ -- According to the recently released follow-up study to the Multimodal Treatment Study on Attention-Deficit/Hyperactivity Disorder (MTA) in the August issue of the Journal of the American Academy of Child and Adolescent Psychiatry (JAACAP), children and young people with AD/HD who received carefully managed medication alone or in combination with behavioral management and educational adaptations fared better than children who did not. However, study participants who no longer received intensive interventions and returned to standard community-based care had lost the initial advantages after three years.

These findings show highly intensive treatment works best when begun early and consistently maintained. If high quality treatment is not continued, the initial benefits may be lost several years later. Lead researcher Peter Jensen, M.D., has emphasized the need for parents and healthcare providers to work closely together for the benefit of the child affected by AD/HD. Unfortunately, recent reports in the media have misrepresented the MTA's findings and drawn unsubstantiated conclusions.

CHADD, Children and Adults with Attention-Deficit/Hyperactivity Disorder, encourages each family to work with their healthcare providers for the most effective treatment for their families and children affected by AD/HD.

To read an interview with Jensen concerning the findings, go to http://www.chadd.org/AM/Template.cfm?Section=Press_Releases1&Template=/CM/C ontentDisplay.cfm&ContentID=5158.


'/>"/>
SOURCE CHADD
Copyright©2007 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. Partners Rx Chief Pharmacy Officer, Richard Bullard on Panel Discussion at the Fall 2007 Managed Markets Summit (MMS) in Phoenix, AZ.
2. Fingertip Formulary Restrictions(TM) Provides Unprecedented Access to Real- Time Managed Care Restrictions Data
3. Medicaid Managed Care Seems to Fall Short
4. States Largest Medicaid Managed Care Plan Offering Training to Combat West Virginia Obesity Epidemic
5. New treatment effective in counteracting cocaine-induced symptoms
6. New treatment boosts muscle function in myasthenia gravis
7. Broad-based group of physicians calls for improvement in stroke treatment
8. Cranberry Could Juice Up Ovarian Cancer Treatment
9. Non-medicinal treatment touted for pre-schoolers with ADHD
10. Nonmedicinal treatment touted for preschoolers with ADHD
11. U of M study: Early treatment can reverse heart damage
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/8/2016)... ... February 08, 2016 , ... Stephanie ... celebrates the beginning of a new charity campaign. As part of their ongoing ... Advocates (CASA). In the belief that children deserve a voice, and in the ...
(Date:2/8/2016)... ... February 08, 2016 , ... Tingley ... into Canada to provide its range of unique and advantaged protective solutions ... City that will provide bilingual customer service and marketing support. A new distribution ...
(Date:2/8/2016)... ... February 08, 2016 , ... ... relationship-marketing firm, announced today that nominations will be accepted February 8, 2016 ... Awards. , Awards include the Information Security Executive® of the Year, ...
(Date:2/8/2016)... , ... February 08, 2016 , ... ... than 50% lower incidence rate of type 2 diabetes in the GrassrootsHealth cohort ... is time to make a change in public health,” states Carole Baggerly, Director ...
(Date:2/8/2016)... ... ... The schedule is now online for the largest and most ... being held May 25-29 at the Loews Chicago O’Hare Hotel, continues to give the ... chronic illness in children. , Very recent articles have cited 1 child in 20 ...
Breaking Medicine News(10 mins):
(Date:2/8/2016)... 2016 Aesthetic Devices - Medical Devices Pipeline ... report, "Aesthetic Devices - Medical Devices Pipeline Assessment, 2015" ... stage. This report is prepared using ... by GlobalData,s team of industry experts. *Note: Certain ... based on the availability and relevance of data in ...
(Date:2/8/2016)... TOKYO and FAIRFIELD, N.J. ... (Otsuka) and Medimetriks Pharmaceuticals, Inc. (Medimetriks) today announced that ... exclusive development and commercialization rights for OPA-15406 in the ... agreement also provides manufacturing rights.  OPA-15406 is a topical, ... for atopic dermatitis. --> ...
(Date:2/8/2016)... 8, 2016  Echo Therapeutics, Inc. (Nasdaq: ... focused on non-invasive continuous glucose monitoring (CGM) ... that it will host a webcast and ... at 9:00 a.m. Eastern Time to provide ... strategy, advancements in its CGM system, and ...
Breaking Medicine Technology: